Menopausal Hormone Therapy: Clinical Benefits and Outcome Studies
In this non-CME webinar, Dr. Doreen Saltiel reviews the limitations of hormone-related guidelines, while demonstrating how the clinical evidence guides prescribing micronized progesterone, estradiol, and testosterone therapy. She also dives deep into which delivery methods and doses improve clinical outcomes.
Since the 2002 Women’s Health Initiative (WHI) publication, menopausal hormone therapy (MHT), especially estrogen (E)/estradiol (E2) replacement therapy (ERT), has been hotly debated. The WHI’s preliminary data release changed clinician practice patterns. Since then, clinicians have struggled with weighing the benefits with the risks. Since women spend approximately 1/3 of their lives hormone insufficient/deficient, it is important to understand MHT’s benefits and risks and how they may impact your patients and practice.
Click Here for the special offers mentioned in the video!